Key Takeaways
- • Third Point Investors Limited, a London-listed feeder fund for Dan Loeb's New York hedge fund Third Point, is seeking to combine with Malibu Life Reinsurance, converting the investment trust into a life and annuity reinsurance company.
- • Loeb won a shareholder vote on August 14 to proceed with the contentious merger despite a fierce backlash from some investors, according to publisher coverage of the vote.
- • The plan has drawn opposition from rival activist investors, with reports of a shareholder revolt and an extraordinary public dispute between Loeb and UK-based activists.
- • The Financial Times Lex column argues the outcome is a London-listed governance fight that has reached the point where the UK market has effectively gotten what it asked for, while critics question whether the merger will deliver value to shareholders.
Summary
Third Point Investors Limited, a London-listed feeder fund for Dan Loeb's New York hedge fund, is attempting to combine with Malibu Life Reinsurance, an offshore insurer. The proposal would turn the listed investment trust into a life and annuity reinsurance company. According to publisher coverage, Loeb secured a shareholder vote on August 14 to proceed with the merger, overcoming a fierce backlash from some investors.
The transaction has drawn significant opposition. Coverage describes a shareholder revolt against the plan, and reports note that Loeb's London vehicle has itself become a target of activist investors, a reversal that has produced a public spat between the parties. Earlier coverage also reported the departure of the fund's chairman, which Loeb attributed to "inexperienced" activists, and a subsequent exchange in which Loeb criticized activists in strong terms.
The Financial Times Lex column, titled "London gets what it asked for with Dan Loeb's hedge fund fight," frames the dispute as a test of whether the merger will deliver value for shareholders. Separate FT commentary has described the outcome as a potentially Pyrrhic victory for Loeb if the plan fails to create shareholder value. The debate centres on whether converting a listed trust into an insurance vehicle serves minority investors, a question of direct relevance to allocators holding London-listed closed-end vehicles.
The transaction has drawn significant opposition. Coverage describes a shareholder revolt against the plan, and reports note that Loeb's London vehicle has itself become a target of activist investors, a reversal that has produced a public spat between the parties. Earlier coverage also reported the departure of the fund's chairman, which Loeb attributed to "inexperienced" activists, and a subsequent exchange in which Loeb criticized activists in strong terms.
The Financial Times Lex column, titled "London gets what it asked for with Dan Loeb's hedge fund fight," frames the dispute as a test of whether the merger will deliver value for shareholders. Separate FT commentary has described the outcome as a potentially Pyrrhic victory for Loeb if the plan fails to create shareholder value. The debate centres on whether converting a listed trust into an insurance vehicle serves minority investors, a question of direct relevance to allocators holding London-listed closed-end vehicles.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.